Assessment tools and outcomes in real–world migraine patients eligible for treatment with an anti–calcitonin gene–related peptide antibody - Kasai Hideyo; Watanabe Keiko; Yasumoto Taro; Mizuma Keita; Futamura Akinori; Kuroda Takeshi; Yano Satoshi; Hieda Sotaro; Ono Kenjiro; Murakami Hidetomo (神経治療学, 2024)
Keywords: fremanezumab; galcanezumab; migraine; migraine disability assessment; real–world evidence